Collagen & Gelatin Market Size & Forecast [2033]

Collagen & Gelatin Market Overview

The Collagen & Gelatin Market size was valued at USD 929.12 million in 2024 and is expected to reach USD 1597.86 million by 2033, growing at a CAGR of 6.1% from 2025 to 2033.

The global collagen and gelatin market is experiencing significant growth, driven by increasing applications across various industries. In 2023, the market was valued at approximately $1.2 billion, with projections indicating a rise to $2.2 billion by 2034. This growth is attributed to the rising demand for collagen and gelatin in pharmaceuticals, food and beverages, cosmetics, and nutraceuticals.

Notably, North America held the largest market share in 2024, accounting for about 35% of the global market, followed by Europe. Asia-Pacific is expected to register the highest growth rate during the forecast period, driven by increasing applications in research and clinical diagnostics, as well as government initiatives and industrial collaborations.

report_graphAlt

Key Findings

Driver: The primary driver of the collagen and gelatin market is the rising demand for pharmaceuticals.

Top Country/Region: North America leads the market, with the United States accounting for approximately 35% of the global market share.

Top Segment: The food and beverage segment dominates the market, driven by the increasing use of collagen and gelatin in various food products.

Collagen & Gelatin Market Trends

The collagen and gelatin market is witnessing several notable trends that are shaping its growth trajectory. One significant trend is the increasing use of collagen and gelatin in the food and beverage industry. In 2021, the food and beverages segment dominated the global market, with gelatin being widely used in food production processes to produce high-protein diets. Another trend is the growing popularity of edible beauty products, such as supplements and vitamin gummies, driven by a shift in consumer preferences towards beauty from within. The beauty supplements sector grew by 9.4% to $2.68 billion in 2023 and is projected to grow at a compound annual rate of 13.6% over the next decade.

Social media platforms like TikTok have also contributed to the rising interest in gelatin-based recipes, with users creating and consuming gelatin-based products for their supposed health benefits. Gelatin, derived from sources such as animal skin, cartilage, and connective tissue, is rich in amino acids and collagen, supporting skin elasticity, hydration, and overall health of bones, muscles, gut, nails, and hair. In Asia-Pacific, particularly China, the edible beauty market is expanding rapidly. Between 2013 and 2015, the edible beauty market in China grew by RMB 3.1 billion and is expected to reach RMB 23.8 billion by 2022. This growth is inspired by traditional Chinese medicine theories that internal health can enhance external appearance, leading to increased demand for ingestible beauty products like collagen gummies and hyaluronic acid drinks.

Collagen & Gelatin Market Dynamics

DRIVER

Rising demand for pharmaceuticals.

The pharmaceutical industry is a significant driver of the collagen and gelatin market. Collagen and gelatin are widely used in the production of capsules and hard gels due to their capacity to shield delicate contents from air and microbial growth. This application is particularly important in ensuring the stability and efficacy of pharmaceutical products. The increasing prevalence of chronic diseases and the growing aging population have led to a surge in demand for pharmaceutical products, thereby boosting the demand for collagen and gelatin. Additionally, the use of collagen and gelatin in wound care products, such as dressings and scaffolds, further contributes to market growth.

RESTRAINT

Demand for refurbished equipment.

One of the main restraints in the collagen and gelatin market is the demand for refurbished equipment, which can hinder the adoption of new technologies and processes. The use of outdated or refurbished equipment may lead to inefficiencies in production, affecting the quality and consistency of collagen and gelatin products. Moreover, the high cost associated with upgrading to advanced equipment can be a barrier for small and medium-sized enterprises, limiting their ability to compete in the market. This restraint can slow down the overall growth of the market, especially in developing regions where access to modern equipment is limited.

OPPORTUNITY

Growth in personalized medicines.

The growth in personalized medicines presents a significant opportunity for the collagen and gelatin market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, which requires specialized drug delivery systems. Collagen and gelatin are ideal materials for developing such systems due to their biocompatibility and biodegradability. They can be used to create customized drug delivery vehicles that release therapeutic agents at controlled rates, enhancing treatment efficacy and patient compliance. As the demand for personalized medicine continues to rise, the need for advanced drug delivery systems incorporating collagen and gelatin is expected to increase, offering lucrative opportunities for market players.

CHALLENGE

Rising costs and expenditures.

The collagen and gelatin market faces challenges related to rising costs and expenditures. The production of high-quality collagen and gelatin requires significant investment in raw materials, processing technologies, and quality control measures. Fluctuations in the prices of raw materials, such as animal hides and bones, can impact production costs. Additionally, stringent regulatory requirements necessitate continuous investment in research and development to ensure compliance, further increasing operational costs. These rising expenditures can affect profit margins, particularly for small and medium-sized enterprises, and may hinder market growth if not managed effectively.

Collagen & Gelatin Market Segmentation

The collagen and gelatin market is segmented based on type and application. By type, the market includes bovine, porcine, and marine sources. By application, it encompasses wound care, orthopedic, and cardiovascular uses.

report_graphAlt

By Type

Bovine: derived collagen and gelatin are widely used due to their high availability and cost-effectiveness. They are primarily sourced from cow hides and bones and are commonly used in food, pharmaceutical, and cosmetic applications. The bovine segment holds a significant share of the market, driven by the increasing demand for collagen supplements and functional foods. However, concerns related to bovine spongiform encephalopathy (BSE) have led to stringent regulations, impacting the growth of this segment.
Porcine: collagen and gelatin are derived from pig skin and bones and are known for their excellent gelling properties. They are extensively used in the food industry for products like gummy candies and marshmallows. The porcine segment is also significant in pharmaceutical applications, particularly in the production of capsules. Cultural and religious restrictions in certain regions may limit the use of porcine-derived products, affecting market growth in those areas.
Marine: collagen and gelatin are extracted from fish skin and scales and are gaining popularity due to their high bioavailability and lower risk of disease transmission. They are increasingly used in cosmetic and nutraceutical products aimed at improving skin health and joint function. The marine segment is expected to witness substantial growth, driven by the rising demand for sustainable and ethically sourced ingredients.

By Application

Wound Care: Collagen and gelatin are integral components in wound care products due to their ability to promote healing and tissue regeneration. They are used in dressings, sponges, and scaffolds to manage chronic wounds, burns, and surgical incisions. The increasing prevalence of chronic wounds and the growing aging population contribute to the demand for collagen and gelatin-based wound care products.
Orthopedic: applications, collagen and gelatin are utilized in the development of bone grafts, cartilage repair materials, and joint supplements. Their biocompatibility and ability to support tissue regeneration make them suitable for treating musculoskeletal disorders. The rising incidence of orthopedic conditions, such as osteoarthritis and fractures, drives the demand for collagen and gelatin in this segment.
Cardiovascular: Collagen and gelatin are employed in cardiovascular applications, including the fabrication of vascular grafts, heart valves, and hemostatic agents. Their use in these applications is attributed to their mechanical strength and compatibility with human tissues. The increasing prevalence of cardiovascular diseases and the need for advanced treatment options fuel the growth of this segment.

Collagen & Gelatin Market Regional Outlook

The collagen and gelatin market exhibits varying performance across different regions.

North America

dominates the global collagen and gelatin market, accounting for approximately 35% of the global market share. The United States leads the region, driven by the booming health and wellness industry. Over 70% of U.S. consumers actively seek collagen-based dietary supplements, particularly for skin and joint health. Canada has also experienced strong growth due to increased demand for nutraceuticals and protein-enriched foods. In 2024, the region recorded over 1,200 collagen-based product launches, with dietary supplements making up more than 45% of this total. The North American market also benefits from well-established healthcare infrastructure and ongoing R&D initiatives into regenerative medicine using collagen and gelatin.

Europe

holds a substantial share of the collagen and gelatin market, supported by rising demand for bio-based materials in food, pharmaceuticals, and cosmetics. In 2023, Germany, France, and the UK collectively contributed to over 60% of the regional demand. Germany leads the way with more than 300 companies involved in collagen and gelatin processing. The European market is driven by the consumer preference for clean-label and ethically sourced products. Marine collagen is gaining rapid traction here, particularly in France and Scandinavian countries, with an annual usage growth rate of over 12% between 2022 and 2024. Regulatory support from EFSA for collagen-based health claims also plays a pivotal role in product innovation and market expansion.

Asia-Pacific

is emerging as the fastest-growing region in the collagen and gelatin market. Countries like China, Japan, South Korea, and India are spearheading demand due to rising health awareness and aging populations. China’s edible beauty industry, valued at over RMB 23.8 billion in 2022, continues to boost collagen consumption. Japan’s functional food segment integrates collagen in over 50% of its nutricosmetics. South Korea saw a 14% increase in collagen-infused skincare product launches from 2023 to 2024. India’s pharmaceutical and food processing industries are expanding significantly, with over 600 collagen-based formulations introduced in 2023 alone. Favorable government initiatives and increased healthcare expenditure are further fueling growth.

Middle East & Africa

region is gradually gaining prominence in the collagen and gelatin market. In 2023, the region accounted for approximately 5% of global demand, with South Africa, UAE, and Saudi Arabia being key contributors. Increasing investment in healthcare infrastructure and food processing is driving market expansion. UAE has seen a 20% year-over-year rise in demand for halal-certified collagen supplements. Additionally, the cosmetic industry in the region is adopting marine and bovine collagen for anti-aging skincare products. Despite challenges in raw material sourcing and technological adoption, the market is witnessing steady growth, particularly in urban centers.

List of Top Collagen & Gelatin Companies

Integra Lifesciences Holdings Corporation
Collagen Matrix Inc.
Collagen Solutions PLC
Royal DSM
Vornia Biomaterials Ltd.
Symatese
Nucollagen, LLC.
Gelita AG
Nitta Gelatin Inc.
PB Gelatin

Gelita AG: holds one of the highest shares in the global market, with more than 20 production sites worldwide and an annual output exceeding 85,000 metric tons of gelatin and collagen peptides in 2023. The company serves over 100 countries and dominates the nutraceutical and food industry segments.

Nitta Gelatin Inc.: ranks among the top with a strong presence in Asia and North America. The company processed over 60,000 metric tons of collagen and gelatin products globally in 2024. Their extensive portfolio caters to food, pharmaceutical, and biomedical applications.

Investment Analysis and Opportunities

The collagen and gelatin market has become an attractive segment for investors, driven by rising demand across food, pharmaceuticals, and cosmetic sectors. In 2023, private equity and venture capital firms invested over $900 million globally into companies focusing on collagen extraction, processing technologies, and product innovation. Notably, over 150 startups emerged in Asia and Europe, focusing on marine and plant-based collagen alternatives, reflecting a shift toward sustainability. Pharmaceutical companies are allocating larger budgets for gelatin-based drug delivery systems. For example, in 2024, more than 75 new pharmaceutical products containing gelatin capsules were approved in North America alone. This trend opens significant opportunities for gelatin manufacturers focusing on clean and high-purity grades. In food and beverage, companies are targeting functional food lines with enhanced protein and collagen content.

PepsiCo, for instance, launched a new line of collagen-infused beverages in the Asia-Pacific market in early 2024, with an estimated initial production run of over 1 million units per quarter. Investments are also being funneled into bioprinting and tissue engineering. In 2023, over $300 million was invested globally into collagen-based scaffolds for regenerative medicine. Hospitals and research institutes in the U.S. and EU are partnering with suppliers to develop collagen matrices for wound healing and orthopedic grafts. The growing vegan and plant-based trend is pushing R&D spending toward collagen mimetics, with biotech firms raising over $120 million in 2024 to develop recombinant collagen alternatives. These investments indicate a long-term shift toward innovation-driven market growth. The market is likely to see sustained investor interest as consumer preferences evolve and applications diversify further into niche health segments.

New Product Development

Innovation in the collagen and gelatin market is robust, with manufacturers focusing on value-added products, cleaner formulations, and novel applications. Between 2023 and 2024, over 2,000 new products containing collagen or gelatin were introduced globally, spanning food, health supplements, and personal care. In the functional food space, manufacturers are adding collagen to coffee, protein bars, and instant soups. In 2024, a U.S.-based food tech firm launched a collagen-fortified granola bar line, selling over 500,000 units within the first six months. Similarly, in Japan, collagen-added miso soup sachets became a top-selling functional product, with annual sales surpassing 2 million packs in 2023. Cosmetic companies are developing topical products combining collagen with other bioactive ingredients like hyaluronic acid and peptides. In South Korea, a leading beauty brand released a marine collagen cream in early 2024, selling 250,000 units within the first quarter.

Edible beauty products, particularly collagen shots and gummies, are gaining traction in China, where new launches grew by 18% in 2023 compared to the previous year. In pharmaceuticals, extended-release gelatin capsules and biodegradable collagen membranes are being developed for improved drug delivery and surgical use. U.S. FDA approved five collagen-based medical devices between 2023 and 2024. This includes wound dressings and dental bone grafts. Biotech firms are focusing on collagen scaffolds for 3D cell culture and organ regeneration. A European startup introduced a recombinant collagen hydrogel in 2024 that mimics native human tissue, with clinical trials scheduled for late 2025. These developments underscore the growing convergence between biotech and traditional collagen applications, opening new frontiers for innovation.

Five Recent Developments

Gelita AG launched its SmartGel™ technology in Q3 2023, a rapid-setting gelatin for confectionery products, reducing setting time by 30% and improving texture consistency.
Nitta Gelatin opened a new R&D center in Japan in early 2024, focusing on marine collagen extraction efficiency and sustainable sourcing, targeting a 15% improvement in yield by 2025.
Royal DSM introduced a vegan-friendly collagen alternative, launched in Europe in mid-2023, aimed at capturing the growing plant-based nutrition market, with pilot sales exceeding 100,000 units.
Collagen Matrix, Inc. received FDA approval for its collagen-based wound care dressing in January 2024, following a clinical trial with 300+ patients showing a 25% faster healing rate.
PB Gelatin entered a joint venture with a Brazilian agribusiness firm in 2023 to utilize bovine by-products for collagen manufacturing, increasing raw material availability by 40%.

Report Coverage of Collagen & Gelatin Market

The comprehensive report on the collagen and gelatin market provides detailed insights into market performance, key drivers, restraints, opportunities, and challenges from 2021 to 2024. It analyzes historical and current trends across segments, including types, applications, and regional performance, covering over 30 countries. The report categorizes the market by three primary collagen types—bovine, porcine, and marine—and by three applications: wound care, orthopedic, and cardiovascular. It offers quantitative data on production volume, usage in each sector, product launches, and import-export analysis. For instance, global collagen imports grew by 18% in 2023, with China, Germany, and the U.S. being the largest importers.

Coverage extends to regulatory frameworks across key regions, with in-depth analysis of FDA, EFSA, and other international standards influencing the manufacturing and labeling of collagen and gelatin products. Technological advancements in hydrolysis, enzymatic processing, and recombinant collagen production are highlighted, along with their respective adoption rates. The report includes company profiles, SWOT analysis, and product pipelines of over 20 key market players. Strategic initiatives such as M&A, capacity expansion, and geographical diversification are discussed, with over 50 transactions recorded between 2022 and 2024. Furthermore, the report evaluates the competitive landscape using metrics such as product differentiation, production capabilities, market penetration, and sustainability initiatives. In 2024, 40% of surveyed companies committed to carbon-neutral production for collagen by 2030, reflecting a shift toward sustainable sourcing and ethical processing.